Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1994 Jul 15;301(Pt 2):313–316. doi: 10.1042/bj3010313

Uptake of nitric oxide synthase inhibitors by macrophage RAW 264.7 cells.

K Schmidt 1, P Klatt 1, B Mayer 1
PMCID: PMC1137080  PMID: 7519006

Abstract

Uptake of the nitric oxide synthase inhibitors NG-methyl-L-arginine (L-NMA) and NG-nitro-L-arginine (L-NNA) by macrophages is mediated by two different mechanisms. Activation of the cells with cytokines resulted in an up-regulation of L-NMA uptake but did not affect L-NNA transport. Characterization of the transport sites revealed that uptake of L-NMA is mediated by a cationic amino acid transporter (system y+) whereas a neutral amino acid transporter (system L) accounts for the uptake of L-NNA.

Full text

PDF
315

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baydoun A. R., Bogle R. G., Pearson J. D., Mann G. E. Selective inhibition by dexamethasone of induction of NO synthase, but not of induction of L-arginine transport, in activated murine macrophage J774 cells. Br J Pharmacol. 1993 Dec;110(4):1401–1406. doi: 10.1111/j.1476-5381.1993.tb13976.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bogle R. G., Baydoun A. R., Pearson J. D., Moncada S., Mann G. E. L-arginine transport is increased in macrophages generating nitric oxide. Biochem J. 1992 May 15;284(Pt 1):15–18. doi: 10.1042/bj2840015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Christensen H. N. Distinguishing amino acid transport systems of a given cell or tissue. Methods Enzymol. 1989;173:576–616. doi: 10.1016/s0076-6879(89)73040-8. [DOI] [PubMed] [Google Scholar]
  4. Chénais B., Yapo A., Lepoivre M., Tenu J. P. N omega-hydroxy-L-arginine, a reactional intermediate in nitric oxide biosynthesis, induces cytostasis in human and murine tumor cells. Biochem Biophys Res Commun. 1993 Nov 15;196(3):1558–1565. doi: 10.1006/bbrc.1993.2429. [DOI] [PubMed] [Google Scholar]
  5. Feldman P. L., Griffith O. W., Hong H., Stuehr D. J. Irreversible inactivation of macrophage and brain nitric oxide synthase by L-NG-methylarginine requires NADPH-dependent hydroxylation. J Med Chem. 1993 Feb 19;36(4):491–496. doi: 10.1021/jm00056a009. [DOI] [PubMed] [Google Scholar]
  6. Furfine E. S., Harmon M. F., Paith J. E., Garvey E. P. Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine. Biochemistry. 1993 Aug 24;32(33):8512–8517. doi: 10.1021/bi00084a017. [DOI] [PubMed] [Google Scholar]
  7. Förstermann U., Schmidt H. H., Pollock J. S., Sheng H., Mitchell J. A., Warner T. D., Nakane M., Murad F. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol. 1991 Oct 24;42(10):1849–1857. doi: 10.1016/0006-2952(91)90581-o. [DOI] [PubMed] [Google Scholar]
  8. Gross S. S., Stuehr D. J., Aisaka K., Jaffe E. A., Levi R., Griffith O. W. Macrophage and endothelial cell nitric oxide synthesis: cell-type selective inhibition by NG-aminoarginine, NG-nitroarginine and NG-methylarginine. Biochem Biophys Res Commun. 1990 Jul 16;170(1):96–103. doi: 10.1016/0006-291x(90)91245-n. [DOI] [PubMed] [Google Scholar]
  9. Hibbs J. B., Jr, Taintor R. R., Vavrin Z., Rachlin E. M. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun. 1988 Nov 30;157(1):87–94. doi: 10.1016/s0006-291x(88)80015-9. [DOI] [PubMed] [Google Scholar]
  10. Lambert L. E., Whitten J. P., Baron B. M., Cheng H. C., Doherty N. S., McDonald I. A. Nitric oxide synthesis in the CNS endothelium and macrophages differs in its sensitivity to inhibition by arginine analogues. Life Sci. 1991;48(1):69–75. doi: 10.1016/0024-3205(91)90426-c. [DOI] [PubMed] [Google Scholar]
  11. Low B. C., Ross I. K., Grigor M. R. Characterization of system L and system y+ amino acid transport activity in cultured vascular smooth muscle cells. J Cell Physiol. 1993 Sep;156(3):626–634. doi: 10.1002/jcp.1041560323. [DOI] [PubMed] [Google Scholar]
  12. McCall T. B., Feelisch M., Palmer R. M., Moncada S. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. Br J Pharmacol. 1991 Jan;102(1):234–238. doi: 10.1111/j.1476-5381.1991.tb12159.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nathan C. F., Hibbs J. B., Jr Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol. 1991 Feb;3(1):65–70. doi: 10.1016/0952-7915(91)90079-g. [DOI] [PubMed] [Google Scholar]
  14. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992 Sep;6(12):3051–3064. [PubMed] [Google Scholar]
  15. Olken N. M., Marletta M. A. NG-methyl-L-arginine functions as an alternate substrate and mechanism-based inhibitor of nitric oxide synthase. Biochemistry. 1993 Sep 21;32(37):9677–9685. doi: 10.1021/bi00088a020. [DOI] [PubMed] [Google Scholar]
  16. Olken N. M., Rusche K. M., Richards M. K., Marletta M. A. Inactivation of macrophage nitric oxide synthase activity by NG-methyl-L-arginine. Biochem Biophys Res Commun. 1991 Jun 14;177(2):828–833. doi: 10.1016/0006-291x(91)91864-9. [DOI] [PubMed] [Google Scholar]
  17. Palmer R. M., Ashton D. S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988 Jun 16;333(6174):664–666. doi: 10.1038/333664a0. [DOI] [PubMed] [Google Scholar]
  18. Sakuma I., Stuehr D. J., Gross S. S., Nathan C., Levi R. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad Sci U S A. 1988 Nov;85(22):8664–8667. doi: 10.1073/pnas.85.22.8664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sato H., Fujiwara M., Bannai S. Effect of lipopolysaccharide on transport and metabolism of arginine in mouse peritoneal macrophages. J Leukoc Biol. 1992 Aug;52(2):161–164. doi: 10.1002/jlb.52.2.161. [DOI] [PubMed] [Google Scholar]
  20. Sato H., Ishii T., Sugita Y., Bannai S. Induction of cationic amino acid transport activity in mouse peritoneal macrophages by lipopolysaccharide. Biochim Biophys Acta. 1991 Oct 14;1069(1):46–52. doi: 10.1016/0005-2736(91)90102-e. [DOI] [PubMed] [Google Scholar]
  21. Schmidt H. H., Nau H., Wittfoht W., Gerlach J., Prescher K. E., Klein M. M., Niroomand F., Böhme E. Arginine is a physiological precursor of endothelium-derived nitric oxide. Eur J Pharmacol. 1988 Sep 13;154(2):213–216. doi: 10.1016/0014-2999(88)90101-x. [DOI] [PubMed] [Google Scholar]
  22. Schmidt K., Klatt P., Mayer B. Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors. Mol Pharmacol. 1993 Sep;44(3):615–621. [PubMed] [Google Scholar]
  23. Stuehr D. J., Kwon N. S., Gross S. S., Thiel B. A., Levi R., Nathan C. F. Synthesis of nitrogen oxides from L-arginine by macrophage cytosol: requirement for inducible and constitutive components. Biochem Biophys Res Commun. 1989 Jun 15;161(2):420–426. doi: 10.1016/0006-291x(89)92615-6. [DOI] [PubMed] [Google Scholar]
  24. Westergaard N., Beart P. M., Schousboe A. Transport of L-[3H]arginine in cultured neurons: characteristics and inhibition by nitric oxide synthase inhibitors. J Neurochem. 1993 Jul;61(1):364–367. doi: 10.1111/j.1471-4159.1993.tb03579.x. [DOI] [PubMed] [Google Scholar]
  25. Wiemer G., Wellstein A., Palm D., von Hattingberg H. M., Brockmeier D. Properties of agonist binding at the beta-adrenoceptor of the rat reticulocyte. Naunyn Schmiedebergs Arch Pharmacol. 1982 Oct;321(1):11–19. doi: 10.1007/BF00586342. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES